Clinical Trials Browser

Phase 2 × Completed × Pituitary Diseases × Clear all

Pituitary Diseases, Pituitary Neoplasms

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT00054756 2018-08-08

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities

Phase 2 Completed

96 enrolled 6 charts

EndocrineHead & Neck

Hypothyroidism, Pituitary Diseases, Pituitary Neoplasms, Thyroid Diseases

Clinical Trials

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities